Basic Information
| RNALocate ID: | RLID:11001969 |
| RNA Symbol: | hsa-miR-190a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-190a-5p |
| RNA ID: | miRBase:MIMAT0000458 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11001968 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11001970 | Exosome | Plasma | 23663360 |
| RLID:11001971 | Exosome | Plasma | 24683445 |
| RLID:11001972 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID-D:11000386 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells|Urine | |
| RLID-D:11001184 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-190a-5p | Cardiomyopathies | MNDR-E-MI-22104 |
| MNDR | hsa-miR-190a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-22105 |
| MNDR | hsa-miR-190a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-22106 |
| MNDR | hsa-miR-190a-5p | Medulloblastoma | MNDR-E-MI-22107 |
| MNDR | hsa-miR-190a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-22108 |
| MNDR | hsa-miR-190a-5p | Lymphoma non-hodgkin | MNDR-E-MI-22109 |
| MNDR | hsa-miR-190a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-22110 |
| MNDR | hsa-miR-190a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-22111 |
| MNDR | hsa-miR-190a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-22112 |
| MNDR | hsa-miR-190a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-22113 |
| MNDR | hsa-miR-190a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-22114 |
| MNDR | hsa-miR-190a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-22115 |
| MNDR | hsa-miR-190a-5p | Dermatomyositis | MNDR-E-MI-22116 |
| MNDR | hsa-miR-190a-5p | Prostate cancer | MNDR-E-MI-22117 |
| MNDR | hsa-miR-190a-5p | Gastric cancer | MNDR-E-MI-22118 |
| MNDR | hsa-miR-190a-5p | Alzheimer disease | MNDR-E-MI-22119 |
| MNDR | hsa-miR-190a-5p | Esophageal carcinoma | MNDR-E-MI-22120 |
| MNDR | hsa-miR-190a-5p | Dysautonomia familial | MNDR-E-MI-22121 |
| MNDR | hsa-miR-190a-5p | Ataxia telangiectasia | MNDR-E-MI-22122 |
| MNDR | hsa-miR-190a-5p | Huntington disease | MNDR-E-MI-22123 |
| MNDR | hsa-miR-190a-5p | Lung cancer | MNDR-E-MI-22124 |
| MNDR | hsa-miR-190a-5p | Parkinson disease | MNDR-E-MI-22125 |
| MNDR | hsa-miR-190a-5p | Breast cancer | MNDR-E-MI-22126 |
| MNDR | hsa-miR-190a-5p | Thyroid cancer | MNDR-E-MI-22127 |
| MNDR | hsa-miR-190a-5p | Pancreatic cancer | MNDR-E-MI-22128 |
| MNDR | hsa-miR-190a-5p | Melanoma | MNDR-E-MI-22129 |
| MNDR | hsa-miR-190a-5p | Nephroblastoma | MNDR-E-MI-22130 |
| MNDR | hsa-miR-190a-5p | Colon cancer | MNDR-E-MI-22131 |
| MNDR | hsa-miR-190a-5p | Colon adenocarcinoma | MNDR-E-MI-22132 |
| MNDR | hsa-miR-190a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-22133 |
| MNDR | hsa-miR-190a-5p | Ovarian neoplasms | MNDR-E-MI-22134 |
| MNDR | hsa-miR-190a-5p | Prostate adenocarcinoma | MNDR-E-MI-22135 |
| MNDR | hsa-miR-190a-5p | Carcinoma ductal breast | MNDR-E-MI-22136 |
| MNDR | hsa-miR-190a-5p | Glioblastoma | MNDR-E-MI-22137 |
| MNDR | hsa-miR-190a-5p | Glioma | MNDR-E-MI-22138 |
| MNDR | hsa-miR-190a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-22139 |
| MNDR | hsa-miR-190a-5p | Epilepsy temporal lobe | MNDR-E-MI-22140 |
| MNDR | hsa-miR-190a-5p | Liposarcoma | MNDR-E-MI-22141 |
| MNDR | hsa-miR-190a-5p | Inclusion body myositis | MNDR-E-MI-22142 |
| MNDR | hsa-miR-190a-5p | Meningioma | MNDR-E-MI-22143 |
| MNDR | hsa-miR-190a-5p | Uterine cancer | MNDR-E-MI-22144 |
| MNDR | hsa-miR-190a-5p | Gastric adenocarcinoma | MNDR-E-MI-22145 |
| MNDR | hsa-miR-190a-5p | Lung squamous cell carcinoma | MNDR-E-MI-22146 |
| MNDR | hsa-miR-190a-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-22147 |
| MNDR | hsa-miR-190a-5p | Lung adenocarcinoma | MNDR-E-MI-22148 |
| MNDR | hsa-miR-190a-5p | Thyroid carcinoma | MNDR-E-MI-22149 |
| MNDR | hsa-miR-190a-5p | Bladder urothelial carcinoma | MNDR-E-MI-22150 |
| MNDR | hsa-miR-190a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-22151 |
| MNDR | hsa-miR-190a-5p | Carcinoma renal cell | MNDR-E-MI-22152 |
| MNDR | hsa-miR-190a-5p | Renal clear cell carcinoma | MNDR-E-MI-22153 |
| MNDR | hsa-miR-190a-5p | Esophageal cancer | MNDR-E-MI-22154 |
| MNDR | hsa-miR-190a-5p | HIV | MNDR-E-MI-22155 |
| MNDR | hsa-miR-190a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-22156 |
| MNDR | hsa-miR-190a-5p | Breast invasive carcinoma | MNDR-E-MI-22157 |
| MNDR | hsa-miR-190a-5p | Hepatocellular carcinoma | MNDR-E-MI-22158 |
| MNDR | hsa-miR-190a-5p | B-cell lymphoma | MNDR-E-MI-22159 |
| MNDR | hsa-miR-190a-5p | T-cell leukemia | MNDR-E-MI-22160 |
| MNDR | hsa-miR-190a-5p | Neuromyelitis optica | MNDR-E-MI-22161 |
| MNDR | hsa-miR-190a-5p | Acute myelogenous leukemia | MNDR-E-MI-22162 |
| MNDR | hsa-miR-190a-5p | Colorectal cancer | MNDR-E-MI-22163 |
| MNDR | hsa-miR-190a-5p | Acute lymphocytic leukemia | MNDR-E-MI-22164 |
| MNDR | hsa-miR-190a-5p | Ependymoma | MNDR-E-MI-22165 |
| MNDR | hsa-miR-190a-5p | Prostatic neoplasms | MNDR-E-MI-22166 |
| MNDR | hsa-miR-190a-5p | Arsenic poisoning | MNDR-E-MI-22167 |
| MNDR | hsa-miR-190a-5p | Stroke lacunar | MNDR-E-MI-22168 |
| MNDR | hsa-miR-190a-5p | Breast cancer her3+ negative | MNDR-E-MI-22169 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CDKN1B | Homo sapiens | RR00311901 |
TOP